Managing Dyslipidemia in Adults

A new guideline joins the 2013 ACC/AHA guideline in abandoning treatment to targets, but the two guidelines differ in several important ways.

Sponsoring Organizations: U.S. Department of Veterans Affairs, U.S. Department of Defense

Target Audience: Primary care providers, cardiologists

Background and Objective

In 2014, a panel from the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for managing dyslipidemia. In this synopsis, the authors summarize the guideline's key elements.

Key Recommendations

Eliminate LDL cholesterol and non–HDL cholesterol levels as specific treatment targets. Evidence supports use of moderate, fixed-dose statin therapy to lower risk for early all-cause death and adverse cardiovascular (CV) events.
Routine use of additional testing to refine risk prediction is not recommended. Among v…

Reviewing Authors

Jamaluddin Moloo, MD, MPH

Disclosures

Nothing to disclose

Jamaluddin Moloo, MD, MPH

Disclosures

Nothing to disclose

Allan S. Brett, MD

Disclosures

Grant / Research supportColorado Health Foundation

Allan S. Brett, MD

Disclosures

Grant / Research supportColorado Health Foundation

Managing Dyslipidemia in Adults

Topics

Background and Objective

Key Recommendations

Reviewing Authors